Some relationship between abnormal cholesterol content and impairment of insulin/insulin-like growth factor I (IGF-1) signaling has been reported in the pathogenesis of Alzheimer's disease (AD). The gene discussed is IGF1; the disease is early-onset autosomal dominant Alzheimer disease.